Not applicableWithdrawnNCT06554730What this trial is testingMSD Belzutifan PASWho this might be right forVon Hippel Lindau Disease Merck Sharp & Dohme LLC
Testing effectiveness (Phase 2)Looking for participantsNCT07167329What this trial is testingReal-World Effectiveness and Pharmacogenetics of Belzutifan in VHL Syndrome: The BELIEVE-VHL TrialWho this might be right forVon Hippel LindauVon Hippel Lindau DiseaseVon Hippel Lindau-Deficient Clear Cell Renal Cell Carcinoma+5 more José Claudio Casali da Rocha 100
Testing effectiveness (Phase 2)Ended earlyNCT04267120What this trial is testingLenvatinib (LEN) in Combination With Pembrolizumab (KEYtruda) in Subjects With Locally Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma (The LENKYN Trial)Who this might be right forRenal Cell Carcinoma Washington University School of Medicine 11
Early research (Phase 1)Ended earlyNCT04458259What this trial is testingStudy of PF-07265807 in Participants With Metastatic Solid Tumors.Who this might be right forNeoplasm Metastasis Pfizer 88
Testing effectiveness (Phase 2)Study completedNCT00003683What this trial is testingCombination Chemotherapy in Treating Patients With Metastatic Kidney CancerWho this might be right forKidney Cancer UNICANCER 40
Not applicableStudy completedNCT02156895What this trial is testingPost Marketing Surveillance Study to Observe Safety and Efficacy of Inlyta in South KoreaWho this might be right forAdvanced Renal Cell Carcinoma Pfizer 111
Testing effectiveness (Phase 2)WithdrawnNCT00311545What this trial is testingS0351, CNTO 328 in Treating Patients With Unresectable or Metastatic Kidney CancerWho this might be right forKidney Cancer SWOG Cancer Research Network
Testing effectiveness (Phase 2)Study completedNCT00796757What this trial is testingAvastin (Bevacizumab) in Combination With Low-Dose-Interferon in Patients With Metastatic Clear Cell Renal Cell Carcinoma (RCC).Who this might be right forRenal Cell Cancer Hoffmann-La Roche 146
Early research (Phase 1)Looking for participantsNCT07179770What this trial is testingEffects of Belzutifan on 89Zr-DFO-girentuximab PET Uptake in Patients With Renal Cell Carcinoma (RCC)Who this might be right forMetastatic Clear Cell Renal Cell Carcinoma NYU Langone Health 12
Large-scale testing (Phase 3)Looking for participantsNCT03592472What this trial is testingPazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV)Who this might be right forRenal Cell Carcinoma Xynomic Pharmaceuticals, Inc. 413
Not applicableLooking for participantsNCT01109394What this trial is testingComprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological StudiesWho this might be right forSarcomaEndocrine TumorsNeuroblastoma+2 more National Cancer Institute (NCI) 6,035
Early research (Phase 1)UnknownNCT01381822What this trial is testingDose-Escalation Study of TH-302 in Combination With Sunitinib to Treat Patients With Advanced Renal Cell Carcinoma,Gastrointestinal Stromal Tumors and Pancreatic Neuroendocrine TumorsWho this might be right forAdvanced Renal Cell CarcinomaGastrointestinal Stromal TumorsPancreatic Neuroendocrine Tumors Threshold Pharmaceuticals 58
Early research (Phase 1)Study completedNCT00944905What this trial is testingStudy of MDX-1203 in Subjects With Advanced/Recurrent Clear Cell Renal Cell Carcinoma (ccRCC) or Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (B-NHL)Who this might be right forRenal Cell CarcinomaNon-hodgkin's Lymphoma Bristol-Myers Squibb 46
Early research (Phase 1)Ended earlyNCT01144169What this trial is testingStudy of Hydroxychloroquine Before Surgery in Patients With Primary Renal Cell CarcinomaWho this might be right forRenal Cell Carcinoma University of Pittsburgh 7
Testing effectiveness (Phase 2)Looking for participantsNCT06794229What this trial is testingNeoadjuvant Zanzalintinib Plus Nivolumab in Patients With Locally Advanced and/or Inoperable Clear Cell Renal Cell Carcinoma With or Without Non-measurable MetastasisWho this might be right forLocally Advanced Renal Cell Carcinoma Qian Qin 69
Not applicableStudy completedNCT06656039What this trial is testingA Multimodal Predictive Recurrence Score for Patients With Clear Cell Renal Cell CarcinomaWho this might be right forRenal Cell Carcinoma, Clear Cell RenJi Hospital 1,200
Testing effectiveness (Phase 2)Looking for participantsNCT07226544What this trial is testingIvonescimab Prior to Surgery for the Treatment of High-Risk Localized Clear Cell Renal Cell CancerWho this might be right forLocalized Clear Cell Renal Cell CarcinomaResectable Clear Cell Renal Cell CarcinomaStage II Renal Cell Cancer AJCC v8+2 more City of Hope Medical Center 31
Not applicableStudy completedNCT06317207What this trial is testingEvaluation of the Safety of Reoperation for Ipsilateral Recurrent Tumors After Nephron-sparing Partial NephrectomyWho this might be right forRenal Cell CarcinomaRobotic Surgical Procedures The First Affiliated Hospital of Anhui Medical University 15
Not applicableStudy completedNCT01931644What this trial is testingAt-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic ConditionsWho this might be right forAll Diagnosed Health ConditionsADD/ADHDAlopecia Areata+58 more Sanguine Biosciences 17,667
Not applicableActive Not RecruitingNCT05696444What this trial is testingMedtronic Hugo™ Robotic Assisted Surgery (RAS) System in Urologic Surgery (Expand URO)Who this might be right forBladder CancerProstate CancerKidney Cancer+6 more Medtronic - MITG 144